Comtech Telecommunications Corp. Receives $4.0 Million Contract Award for High-Power Amplifiers for Medical Application
January 10, 2017 at 10:00 AM EST
MELVILLE, N.Y.--(BUSINESS WIRE)--
January 10, 2017-- Comtech Telecommunications Corp. (Nasdaq:CMTL)
announced today that during its second quarter of fiscal 2017, its New
York-based subsidiary, Comtech PST Corp., which is part of Comtech's
Government Solutions segment, has received a follow-on contract award
for approximately $4.0 million for solid-state, high-power RF amplifiers
from a major domestic medical instrumentation provider.
These amplifiers are used by one of the world's largest suppliers of
image-guided radiotherapy (IGRT) and image-guided intensity modulated
radiation therapy (IMRT) medical equipment providing state-of-the-art
solutions for the treatment of cancer. These advanced forms of treatment
deliver versatile complex doses of radiation at greater speed and
accuracy thereby minimizing damage to surrounding healthy tissue.
Fred Kornberg, President and Chief Executive Officer of Comtech
Telecommunications Corp., said, "This significant award demonstrates
Comtech's technical strength in delivering solid-state, high-power RF
amplifiers for medical systems. We believe the medical market for our
amplifiers remains strong and we look forward to continuing to develop
innovative products to address this important market."
Comtech PST Corp. (www.comtechpst.com)
is a leading independent supplier of broadband, high-power, high
performance RF microwave amplifiers for use in a broad spectrum of
applications including defense, medical, satellite communications
systems and instrumentation.
Comtech Telecommunications Corp. designs, develops, produces and markets
innovative products, systems and services for advanced communications
solutions. The Company sells products to a diverse customer base in the
global commercial and government communications markets.
Certain information in this press release contains statements that are
forward-looking in nature and involve certain significant risks and
uncertainties. Actual results could differ materially from such
forward-looking information. The Company's Securities and Exchange
Commission filings identify many such risks and uncertainties. Any
forward-looking information in this press release is qualified in its
entirety by the risks and uncertainties described in such Securities and
Exchange Commission filings.